Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Molecular Diagnostic Techniques | 1 | 2009 | 334 | 0.270 |
Why?
|
| Communicable Diseases | 1 | 2009 | 209 | 0.260 |
Why?
|
| Vaginal Smears | 1 | 2007 | 166 | 0.260 |
Why?
|
| Placenta | 2 | 2019 | 561 | 0.240 |
Why?
|
| Gammaproteobacteria | 1 | 2024 | 20 | 0.230 |
Why?
|
| Papillomaviridae | 1 | 2007 | 636 | 0.220 |
Why?
|
| Hand Injuries | 1 | 2023 | 19 | 0.210 |
Why?
|
| Lacerations | 1 | 2023 | 35 | 0.210 |
Why?
|
| Lasers | 1 | 2023 | 235 | 0.200 |
Why?
|
| Fungi | 1 | 2023 | 147 | 0.200 |
Why?
|
| Mycoplasma genitalium | 1 | 2021 | 2 | 0.200 |
Why?
|
| Mycoplasma Infections | 1 | 2021 | 9 | 0.190 |
Why?
|
| Phage Therapy | 1 | 2021 | 25 | 0.190 |
Why?
|
| Bacteriuria | 1 | 2022 | 84 | 0.190 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 200 | 0.160 |
Why?
|
| Prosthesis-Related Infections | 1 | 2021 | 230 | 0.160 |
Why?
|
| Blood Culture | 1 | 2019 | 33 | 0.160 |
Why?
|
| Enema | 1 | 2018 | 48 | 0.160 |
Why?
|
| Gram-Positive Bacteria | 1 | 2019 | 68 | 0.160 |
Why?
|
| Papillomavirus Infections | 1 | 2007 | 999 | 0.150 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 345 | 0.150 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2018 | 168 | 0.150 |
Why?
|
| Zika Virus | 1 | 2019 | 150 | 0.140 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 511 | 0.140 |
Why?
|
| Zika Virus Infection | 1 | 2019 | 174 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2024 | 1024 | 0.120 |
Why?
|
| Clostridium Infections | 1 | 2018 | 262 | 0.120 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 440 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 1301 | 0.110 |
Why?
|
| Health Care Costs | 1 | 2019 | 699 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 625 | 0.110 |
Why?
|
| Heart-Assist Devices | 1 | 2021 | 1042 | 0.100 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 700 | 0.100 |
Why?
|
| Pregnancy | 5 | 2024 | 8130 | 0.090 |
Why?
|
| Nucleic Acid Probes | 1 | 2009 | 2 | 0.080 |
Why?
|
| Government Regulation | 1 | 2009 | 58 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2009 | 90 | 0.080 |
Why?
|
| Bacterial Typing Techniques | 1 | 2009 | 141 | 0.080 |
Why?
|
| Heart Failure | 1 | 2021 | 2330 | 0.080 |
Why?
|
| Genome, Bacterial | 1 | 2009 | 213 | 0.070 |
Why?
|
| Quality Control | 1 | 2009 | 461 | 0.070 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2007 | 68 | 0.070 |
Why?
|
| Primary Health Care | 2 | 2024 | 831 | 0.070 |
Why?
|
| DNA, Bacterial | 1 | 2009 | 607 | 0.070 |
Why?
|
| False Negative Reactions | 1 | 2007 | 291 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 722 | 0.070 |
Why?
|
| False Positive Reactions | 1 | 2007 | 375 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 5162 | 0.060 |
Why?
|
| Reference Values | 1 | 2007 | 1133 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 596 | 0.060 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2024 | 74 | 0.060 |
Why?
|
| Prevalence | 2 | 2022 | 3404 | 0.060 |
Why?
|
| Ciprofloxacin | 1 | 2024 | 91 | 0.060 |
Why?
|
| ROC Curve | 1 | 2007 | 1248 | 0.050 |
Why?
|
| Drug Resistance, Multiple | 1 | 2024 | 221 | 0.050 |
Why?
|
| Fluoroquinolones | 1 | 2024 | 135 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 4492 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 2471 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2023 | 206 | 0.050 |
Why?
|
| Humans | 12 | 2024 | 270740 | 0.050 |
Why?
|
| Macrolides | 1 | 2021 | 65 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 2573 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2023 | 822 | 0.050 |
Why?
|
| Serologic Tests | 1 | 2020 | 147 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 1076 | 0.040 |
Why?
|
| Pregnant Women | 1 | 2021 | 158 | 0.040 |
Why?
|
| Immunoassay | 1 | 2020 | 214 | 0.040 |
Why?
|
| Term Birth | 1 | 2019 | 34 | 0.040 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2019 | 23 | 0.040 |
Why?
|
| Pediatrics | 1 | 2009 | 1186 | 0.040 |
Why?
|
| RNA, Bacterial | 1 | 2019 | 84 | 0.040 |
Why?
|
| Freeze Drying | 1 | 2018 | 31 | 0.040 |
Why?
|
| Capsules | 1 | 2018 | 54 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2022 | 3187 | 0.040 |
Why?
|
| Equipment Contamination | 1 | 2019 | 85 | 0.040 |
Why?
|
| Female | 7 | 2024 | 148940 | 0.040 |
Why?
|
| Metagenomics | 1 | 2019 | 121 | 0.040 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2021 | 430 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 4960 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2018 | 151 | 0.040 |
Why?
|
| Genomics | 1 | 2009 | 2835 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2024 | 1305 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2021 | 562 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2019 | 1049 | 0.040 |
Why?
|
| Health Expenditures | 1 | 2019 | 202 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2019 | 241 | 0.030 |
Why?
|
| Symptom Assessment | 1 | 2019 | 272 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2023 | 2250 | 0.030 |
Why?
|
| Microcephaly | 1 | 2019 | 333 | 0.030 |
Why?
|
| Syndrome | 1 | 2019 | 1407 | 0.030 |
Why?
|
| Algorithms | 1 | 2007 | 3891 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 514 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 676 | 0.030 |
Why?
|
| Premature Birth | 1 | 2019 | 408 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 1608 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 923 | 0.030 |
Why?
|
| Adult | 4 | 2022 | 82040 | 0.030 |
Why?
|
| Microbiota | 1 | 2019 | 547 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 1610 | 0.020 |
Why?
|
| Young Adult | 2 | 2019 | 22251 | 0.020 |
Why?
|
| Obesity | 1 | 2022 | 2904 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8699 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2021 | 39890 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 7655 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 6509 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 17888 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 13414 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 4208 | 0.020 |
Why?
|
| Middle Aged | 2 | 2024 | 90352 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 7895 | 0.010 |
Why?
|
| Male | 2 | 2024 | 128315 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 30998 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 73333 | 0.010 |
Why?
|